試す 金 - 無料
Trump's $100,000 H1-B fee to hit Indians the hardest
The Sunday Guardian
|September 21, 2025
US President Donald Trump on Saturday (India time) announced a sharp increase in the cost of applying for H1-B visas, raising the fee to $100,000 per petition.
The decision, set to take effect immediately, is projected to hit India hardest, since Indians form the overwhelming majority of H1-B holders and Indian IT firms are among the biggest users of the programme.
According to the latest US Citizenship and Immigration Services (USCIS) data, roughly 2.8 lakh Indians are in the US on HI-B visas-far ahead of China (just over 50,000) and Canada (under 5,000). In FY 2024, USCIS approved 399,395 H1-B petitions, of which 141,205 were for new employment and the rest were renewals and extensions. Around 71-73% of those approvals went to Indian nationals, translating to 191,000 in FY 2023 and 207,000 in FY 2024.
The programme is dominated by large technology firms. Amazon secured 10,044 approvals in FY 2025, followed by Tata Consultancy Services (TCS) with 5,505, Microsoft with 5,189, Meta with 5,123, Apple with 4,202 and Google with 4,181. Based on the Indian share, Amazon alone employs more than 7,000 Indians on H1-Bs, while TCS employs nearly 4,000. Infosys, Wipro, HCL Technologies and Cognizant have also long relied on the visa to place thousands of engineers at client sites in the US
Trump, while justifying the steep hike, claimed that the visa system was "being abused".
Describing it as "terrible," he said it had allowed companies to close IT divisions, fire American staff and hire cheaper foreign workers instead. The proclamation highlighted examples of firms securing thousands of H1-Bs while simultaneously cutting US jobs: one firm approved for 5,000 workers laid off 15,000 employees; another obtained 1,700 visas while cutting 2,400 jobs in Oregon; a third eliminated 27,000 jobs since 2022 while securing 25,000 visas; a fourth cut 1,000 jobs even as it obtained 1,100 H1-Bs. Experts said those unnamed companies were linked to India.
このストーリーは、The Sunday Guardian の September 21, 2025 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
The Sunday Guardian からのその他のストーリー
The Sunday Guardian
THE TERRORIST WHO CAME IN FROM THE COLD
Former insurgent-turned-president navigates shifting alliances while confronting Syria’s deepening internal crises.
5 mins
November 16, 2025
The Sunday Guardian
BJP LOOKS FOR BENGAL ENCORE POST BIHAR TRIUMPH
BJP says Bihar mandate has ‘laid the path’ to power in Bengal, giving oxygen to dislodge Mamata’s 15-year rule.
3 mins
November 16, 2025
The Sunday Guardian
AP, WEF seal 'Energy Cyber Resilience' pact
The Andhra Pradesh government and the World Economic Forum on Saturday signed an agreement to establish a Centre for Energy and Cyber Resilience on the final day of the 30th CII Partnership Summit here.
1 mins
November 16, 2025
The Sunday Guardian
PM’s call to sing Vande Mataram is an invitation, not an imposition
PM's initiative was not about rewriting history but reopening it so that Indians can decide for themselves what their heritage means. That is democracy at its purest essence.
5 mins
November 16, 2025
The Sunday Guardian
Karnataka’s sugarcane crisis escalates
North Karnataka’s sugarcane farmers, who launched a massive agitation over the past two weeks seeking a fair price for their crops, say that the State Government has virtually abandoned them.
1 mins
November 16, 2025
The Sunday Guardian
AKALI DAL SIGNALS REVIVAL THROUGH TARN TARAN BYPOLL
AAP won Tarn Taran bypoll, but the Akalis held on to their support base.
3 mins
November 16, 2025
The Sunday Guardian
AVOIDING AND MANAGING VENOMOUS SNAKE AND OTHER BITES OUTDOORS
Snakebites are a silent global health crisis, claiming an estimated 138,000 fatalities annually, of which 58,000 fatalities, the world's highest, are in India. India hosts over 60 venomous and 240 other snake species. Irula Cooperative Society of tribal snake handlers in Tamil Nadu supplies 80% of the venom for antivenom production in India, a major producer globally. The \"Big Four\" (not by size) venomous Indian snakes are the Russell's viper, saw-scaled viper, Indian cobra, and common krait. Snakes are captured, and venom is carefully extracted before they are released back into the wild. This venom is used to immunize animals like horses or sheep, and the antibodies from their blood are extracted and purified to create antivenom serum (AVS) for human use. These antivenoms are species-specific, costly, difficult to produce, and can provoke dangerous allergic reactions due to the presence of animal antigens. Polyvalent Antivenoms made for these \"Big Four\" do not cover other venomous species like the king cobra, banded Krait, and various pit vipers. Among the numerous Indian antivenom manufacturers, Haffkine Bio-Pharmaceutical Corporation also produces scorpion antivenom. Delayed access to antivenom, poor rural healthcare infrastructure, and transport contribute to a high morbidity (paralysis, bleeding disorders, kidney failure, and amputations) and mortality.
5 mins
November 16, 2025
The Sunday Guardian
TRUMP CUTS TIES WITH MARJORIE T. GREENE
PUBLIC SPLIT
1 min
November 16, 2025
The Sunday Guardian
Time for strategic renewal of India-ROK partnership
India and South Korea must be prepared to support one another in safeguarding their shared democratic values, national sovereignty, a stable Indo-Pacific order, and strategic autonomy amid intensifying great-power competition.
4 mins
November 16, 2025
The Sunday Guardian
Brooklands, a taste of aviation, dining beyond the ordinary
A Michelin-starred aviation-themed restaurant elevates London dining with playful elegance and precision.
4 mins
November 16, 2025
Listen
Translate
Change font size
